FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947724488> ?p ?o ?g. }

• W2947724488 endingPage "103901" @default.
• W2947724488 startingPage "103901" @default.
• W2947724488 abstract "Due to the widespread use of non-nucleoside reverse transcriptase inhibitors (NNRTI) as part of first-line therapies to curb the human immunodeficiency virus (HIV) epidemic in Eastern-European countries, transmitted drug resistance (TDR) is of serious concern in this region. Therefore, TDR and its associated risk factors were investigated among newly diagnosed HIV-1 subjects in Estonia.This nationwide observational study included all newly diagnosed HIV-1 subjects from January 1 until December 31, 2013. Demographic and clinical data were collected using the national surveillance system and the Estonian HIV-positive patient database (E-HIV). Starting from RNA, the HIV-1 protease (PR) and reverse transcriptase (RT) region was sequenced and surveillance drug resistance mutations (SDRM) were determined. Sequences from previous studies in Estonia and from public databases were included to study epidemic trends and to determine TDR clusters by phylogenetic analysis.Out of 325 newly diagnosed HIV-1 infections, 224 were successfully sequenced (68%). As in previous studies from Estonia, the circulating recombinant form CRF06_cpx was the most prevalent HIV subtype (164/224, 74%). Fifteen strains displayed SDRM, giving a TDR rate of 6.7% (95% CI 3.9; 11.0). The most common SDRMs were associated with NNRTI (10/15, 4.5%), followed by PI (3/15, 1.3%) and NRTI (2/15, 0.9%). K103 N (8/15, 53%) was the most common SDRM. The level of TDR and mutational patterns were comparable to previous years. Twenty-six transmission clusters containing Estonian sequences were observed, of which 23/26 belonged to CRF06_cpx and 2/26 displayed evidence of TDR. The only risk factor associated with the presence of TDR was imprisonment (OR 5.187, CI 1.139-25.565, p = 0.034).TDR remained stable at a moderate level in Estonia, K103N is the main SDRM with only one transmission-pair detected. We suggest screening for TDR at the time of diagnosis or prior to antiretroviral treatment initiation to tailor first-line regimens accordingly.The third consecutive transmitted drug resistance (TDR) study demonstrated a stable TDR in Estonia. TDR reached 6.7% (moderate level) in 2013, with imprisonment being the only associated risk factor. Few drug resistance-associated transmission clusters were identified." @default.
• W2947724488 created "2019-06-07" @default.
• W2947724488 creator A5005919014 @default.
• W2947724488 creator A5010067946 @default.
• W2947724488 creator A5017745729 @default.
• W2947724488 creator A5026128828 @default.
• W2947724488 creator A5034933571 @default.
• W2947724488 creator A5035147979 @default.
• W2947724488 creator A5052504717 @default.
• W2947724488 creator A5054064688 @default.
• W2947724488 creator A5055405173 @default.
• W2947724488 creator A5060084318 @default.
• W2947724488 creator A5078838854 @default.
• W2947724488 creator A5087398078 @default.
• W2947724488 date "2019-11-01" @default.
• W2947724488 modified "2023-09-24" @default.
• W2947724488 title "Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy" @default.
• W2947724488 cites W1519266993 @default.
• W2947724488 cites W1722705940 @default.
• W2947724488 cites W173838766 @default.
• W2947724488 cites W1739252816 @default.
• W2947724488 cites W1966031657 @default.
• W2947724488 cites W1985937458 @default.
• W2947724488 cites W1991438233 @default.
• W2947724488 cites W2022574167 @default.
• W2947724488 cites W2023946988 @default.
• W2947724488 cites W2025935798 @default.
• W2947724488 cites W2030033133 @default.
• W2947724488 cites W2041936375 @default.
• W2947724488 cites W2056790245 @default.
• W2947724488 cites W2060575297 @default.
• W2947724488 cites W2065153829 @default.
• W2947724488 cites W2065970143 @default.
• W2947724488 cites W2077284739 @default.
• W2947724488 cites W2128886090 @default.
• W2947724488 cites W2140459214 @default.
• W2947724488 cites W2142678478 @default.
• W2947724488 cites W2153162528 @default.
• W2947724488 cites W2178088856 @default.
• W2947724488 cites W2186581691 @default.
• W2947724488 cites W2198832606 @default.
• W2947724488 cites W2205249602 @default.
• W2947724488 cites W2318289184 @default.
• W2947724488 cites W2504232793 @default.
• W2947724488 cites W2547531753 @default.
• W2947724488 cites W2576188615 @default.
• W2947724488 cites W2582743722 @default.
• W2947724488 cites W2598381200 @default.
• W2947724488 cites W2616933205 @default.
• W2947724488 cites W2657999412 @default.
• W2947724488 cites W2740493740 @default.
• W2947724488 cites W2909867452 @default.
• W2947724488 cites W29905621 @default.
• W2947724488 cites W645011241 @default.
• W2947724488 cites W65942279 @default.
• W2947724488 cites W2007684986 @default.
• W2947724488 doi "https://doi.org/10.1016/j.meegid.2019.05.019" @default.
• W2947724488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31146045" @default.
• W2947724488 hasPublicationYear "2019" @default.
• W2947724488 type Work @default.
• W2947724488 sameAs 2947724488 @default.
• W2947724488 citedByCount "0" @default.
• W2947724488 crossrefType "journal-article" @default.
• W2947724488 hasAuthorship W2947724488A5005919014 @default.
• W2947724488 hasAuthorship W2947724488A5010067946 @default.
• W2947724488 hasAuthorship W2947724488A5017745729 @default.
• W2947724488 hasAuthorship W2947724488A5026128828 @default.
• W2947724488 hasAuthorship W2947724488A5034933571 @default.
• W2947724488 hasAuthorship W2947724488A5035147979 @default.
• W2947724488 hasAuthorship W2947724488A5052504717 @default.
• W2947724488 hasAuthorship W2947724488A5054064688 @default.
• W2947724488 hasAuthorship W2947724488A5055405173 @default.
• W2947724488 hasAuthorship W2947724488A5060084318 @default.
• W2947724488 hasAuthorship W2947724488A5078838854 @default.
• W2947724488 hasAuthorship W2947724488A5087398078 @default.
• W2947724488 hasBestOaLocation W29477244882 @default.
• W2947724488 hasConcept C104317684 @default.
• W2947724488 hasConcept C114851261 @default.
• W2947724488 hasConcept C119599485 @default.
• W2947724488 hasConcept C127413603 @default.
• W2947724488 hasConcept C138885662 @default.
• W2947724488 hasConcept C156719811 @default.
• W2947724488 hasConcept C159047783 @default.
• W2947724488 hasConcept C2776092919 @default.
• W2947724488 hasConcept C41895202 @default.
• W2947724488 hasConcept C49105822 @default.
• W2947724488 hasConcept C54355233 @default.
• W2947724488 hasConcept C71924100 @default.
• W2947724488 hasConcept C761482 @default.
• W2947724488 hasConcept C86803240 @default.
• W2947724488 hasConcept C89423630 @default.
• W2947724488 hasConceptScore W2947724488C104317684 @default.
• W2947724488 hasConceptScore W2947724488C114851261 @default.
• W2947724488 hasConceptScore W2947724488C119599485 @default.
• W2947724488 hasConceptScore W2947724488C127413603 @default.
• W2947724488 hasConceptScore W2947724488C138885662 @default.
• W2947724488 hasConceptScore W2947724488C156719811 @default.
• W2947724488 hasConceptScore W2947724488C159047783 @default.

• next